{"entity":{"type":"insider","cik":"0001859061","url":"/insider/0001859061","json_url":"/insider/0001859061.json","name":"A2A Pharmaceuticals, Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2021-09-21","last":"2023-06-02","span_basis":"filed_date"},"name_variants":[{"name":"A2A Pharmaceuticals, Inc.","source":"filing","n_filings":10,"first_seen":"2021-09-21","last_seen":"2023-06-02"}],"transactions":[{"id":8245834,"accession":"0001859061-23-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001859061-23-000007","line_url":"/filing/0001859061-23-000007#line-2","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":34.5633,"price_display":"34.56","price_state":"stated","total_value":1728165.0,"total_display":"1,728,165.00","total_whole":"1,728,165","shares_owned_after":3500000.0,"shares_owned_after_display":"3,500,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider"},{"id":8245830,"accession":"0001859061-23-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859061-23-000007","line_url":"/filing/0001859061-23-000007#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":33.81,"price_display":"33.81","price_state":"stated","total_value":2535750.0,"total_display":"2,535,750.00","total_whole":"2,535,750","shares_owned_after":3550000.0,"shares_owned_after_display":"3,550,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":7883678,"accession":"0001859061-23-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859061-23-000006","line_url":"/filing/0001859061-23-000006#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":33.84,"price_display":"33.84","price_state":"stated","total_value":846000.0,"total_display":"846,000.00","total_whole":"846,000","shares_owned_after":3625000.0,"shares_owned_after_display":"3,625,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-12","filed_date":"2023-05-17","scope":"insider"},{"id":8663809,"accession":"0001859061-23-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001859061-23-000005","line_url":"/filing/0001859061-23-000005#line-2","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":34.5048,"price_display":"34.50","price_state":"stated","total_value":5175720.0,"total_display":"5,175,720.00","total_whole":"5,175,720","shares_owned_after":3650000.0,"shares_owned_after_display":"3,650,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-10","scope":"insider"},{"id":8663805,"accession":"0001859061-23-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859061-23-000005","line_url":"/filing/0001859061-23-000005#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":33.9931,"price_display":"33.99","price_state":"stated","total_value":3399310.0,"total_display":"3,399,310.00","total_whole":"3,399,310","shares_owned_after":3800000.0,"shares_owned_after_display":"3,800,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-08","filed_date":"2023-05-10","scope":"insider"},{"id":8458616,"accession":"0001859061-23-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859061-23-000004","line_url":"/filing/0001859061-23-000004#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":29.1188,"price_display":"29.12","price_state":"stated","total_value":5823760.0,"total_display":"5,823,760.00","total_whole":"5,823,760","shares_owned_after":3900000.0,"shares_owned_after_display":"3,900,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-26","scope":"insider"},{"id":9296527,"accession":"0001859061-23-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859061-23-000003","line_url":"/filing/0001859061-23-000003#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":31.25,"price_display":"31.25","price_state":"stated","total_value":6250000.0,"total_display":"6,250,000.00","total_whole":"6,250,000","shares_owned_after":4100000.0,"shares_owned_after_display":"4,100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-31","filed_date":"2023-04-06","scope":"insider"},{"id":8346657,"accession":"0001859061-23-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859061-23-000002","line_url":"/filing/0001859061-23-000002#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":31.25,"price_display":"31.25","price_state":"stated","total_value":6250000.0,"total_display":"6,250,000.00","total_whole":"6,250,000","shares_owned_after":4100000.0,"shares_owned_after_display":"4,100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-31","filed_date":"2023-04-06","scope":"insider"},{"id":6873490,"accession":"0001859061-22-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859061-22-000002","line_url":"/filing/0001859061-22-000002#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30684.0,"shares_display":"30,684","price_per_share":13.872,"price_display":"13.87","price_state":"stated","total_value":425648.448,"total_display":"425,648.45","total_whole":"425,648","shares_owned_after":4300000.0,"shares_owned_after_display":"4,300,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-19","scope":"insider"},{"id":6689586,"accession":"0001859061-22-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859061-22-000001","line_url":"/filing/0001859061-22-000001#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34658.0,"shares_display":"34,658","price_per_share":11.21,"price_display":"11.21","price_state":"stated","total_value":388516.18,"total_display":"388,516.18","total_whole":"388,516","shares_owned_after":4330684.0,"shares_owned_after_display":"4,330,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-21","filed_date":"2022-07-25","scope":"insider"},{"id":6137081,"accession":"0001856641-22-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001856641-22-000001","line_url":"/filing/0001856641-22-000001#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34658.0,"shares_display":"34,658","price_per_share":11.76,"price_display":"11.76","price_state":"stated","total_value":407578.08,"total_display":"407,578.08","total_whole":"407,578","shares_owned_after":4365342.0,"shares_owned_after_display":"4,365,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-28","scope":"insider"},{"id":4929866,"accession":"0000899243-21-036769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-036769","line_url":"/filing/0000899243-21-036769#line-1","is_derivative":false,"issuer_cik":"0001840439","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001840439","owner_cik":"0001859061","owner_name":"A2A Pharmaceuticals, Inc.","owner_display_name":"A2A Pharmaceuticals, Inc.","owner_url":"/insider/0001859061","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34658.0,"shares_display":"34,658","price_per_share":10.96,"price_display":"10.96","price_state":"stated","total_value":379851.68,"total_display":"379,851.68","total_whole":"379,852","shares_owned_after":4400000.0,"shares_owned_after_display":"4,400,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840439","name":"Biomea Fusion, Inc.","url":"/issuer/0001840439","role":"Ten percent owner","n_filings":10,"first_seen":"2021-09-21","last_seen":"2023-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001859061","retrieved_at":"2026-08-24T05:34:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}